Stay updated on Dara-VCd vs VTd, Maintenance with IXA Clinical Trial
Sign up to get notified when there's something new on the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page.

Latest updates to the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page
- Check2 days agoChange DetectedRemoved the related topics links for 'Multiple myeloma' and 'MedlinePlus Genetics' from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check9 days agoChange DetectedAdded the disease tag 'Multiple myeloma' and a related topic 'MedlinePlus Genetics' on the page. These changes provide additional context and resources for users viewing the trial details.SummaryDifference0.2%

- Check16 days agoChange DetectedThe page shows Revision: v3.3.3. Footer items and topics, including HHS Vulnerability Disclosure, Multiple myeloma, related topics, MedlinePlus Genetics, and Revision: v3.3.2, were removed.SummaryDifference0.3%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedNew revision v3.3.2 is shown with added related topics 'Multiple myeloma' and 'MedlinePlus Genetics'; the previous revision v3.3.1 appears superseded.SummaryDifference0.2%

- Check45 days agoChange DetectedRevision tag updated to v3.3.1. Older revision tag v3.2.0 and certain related-topic keywords (e.g., 'Multiple myeloma', 'MedlinePlus Genetics') were removed, and these are metadata changes that do not affect the study details.SummaryDifference0.2%

- Check53 days agoChange DetectedThe government funding status notice has been removed from the page. No core trial information appears to have changed.SummaryDifference0.4%

Stay in the know with updates to Dara-VCd vs VTd, Maintenance with IXA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page.